Masson E - Search Results

1

Hyperglycemia and glucosamine-induced mesangial cell cycle arrest and hypertrophy: Common or independent mechanisms?

Masson E, Lagarde M, Wiernsperger N, El Bawab S. Masson E, et al. IUBMB Life. 2006 Jul;58(7):381-8. doi: 10.1080/15216540600755980. IUBMB Life. 2006. PMID: 16801212 Free article. Review.

2

a-Series gangliosides mediate the effects of advanced glycation end products on pericyte and mesangial cell proliferation: a common mediator for retinal and renal microangiopathy?

Masson E, Troncy L, Ruggiero D, Wiernsperger N, Lagarde M, El Bawab S. Masson E, et al. Diabetes. 2005 Jan;54(1):220-7. doi: 10.2337/diabetes.54.1.220. Diabetes. 2005. PMID: 15616032

3

Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.

Masson E, Wiernsperger N, Lagarde M, El Bawab S. Masson E, et al. Glycobiology. 2005 Jun;15(6):585-91. doi: 10.1093/glycob/cwi039. Epub 2004 Dec 29. Glycobiology. 2005. PMID: 15625180

4

Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides.

Masson E, Wiernsperger N, Lagarde M, El Bawab S. Masson E, et al. Biochem J. 2005 Jun 1;388(Pt 2):537-44. doi: 10.1042/BJ20041506. Biochem J. 2005. PMID: 15654767 Free PMC article.

5

O-GlcNAc modification, insulin signaling and diabetic complications.

Issad T, Masson E, Pagesy P. Issad T, et al. Among authors: masson e. Diabetes Metab. 2010 Dec;36(6 Pt 1):423-35. doi: 10.1016/j.diabet.2010.09.001. Epub 2010 Nov 11. Diabetes Metab. 2010. PMID: 21074472 Review.

6

Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice.

Taniguchi K, Xia L, Goldberg HJ, Lee KW, Shah A, Stavar L, Masson EA, Momen A, Shikatani EA, John R, Husain M, Fantus IG. Taniguchi K, et al. Diabetes. 2013 Nov;62(11):3874-86. doi: 10.2337/db12-1010. Epub 2013 Aug 13. Diabetes. 2013. PMID: 23942551 Free PMC article.

7

O-GlcNAcylation of FoxO1 in pancreatic β cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism.

Fardini Y, Masson E, Boudah O, Ben Jouira R, Cosson C, Pierre-Eugene C, Kuo MS, Issad T. Fardini Y, et al. Among authors: masson e. FASEB J. 2014 Feb;28(2):1010-21. doi: 10.1096/fj.13-238378. Epub 2013 Oct 30. FASEB J. 2014. PMID: 24174424

8

O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.

Kanwal S, Fardini Y, Pagesy P, N'tumba-Byn T, Pierre-Eugène C, Masson E, Hampe C, Issad T. Kanwal S, et al. Among authors: masson e. PLoS One. 2013 Jul 11;8(7):e69150. doi: 10.1371/journal.pone.0069150. Print 2013. PLoS One. 2013. PMID: 23935944 Free PMC article.

9

Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.

Shah A, Xia L, Masson EA, Gui C, Momen A, Shikatani EA, Husain M, Quaggin S, John R, Fantus IG. Shah A, et al. J Am Soc Nephrol. 2015 Dec;26(12):2963-77. doi: 10.1681/ASN.2014050528. Epub 2015 Apr 8. J Am Soc Nephrol. 2015. PMID: 25855771 Free PMC article.

10

High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.

Masson E, Koren S, Razik F, Goldberg H, Kwan EP, Sheu L, Gaisano HY, Fantus IG. Masson E, et al. Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1251-61. doi: 10.1152/ajpendo.90619.2008. Epub 2009 Feb 17. Am J Physiol Endocrinol Metab. 2009. PMID: 19223654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters